InsiderSignal.AI

InsiderSignal.ai

APGE - Apogee Therapeutics, Inc.

Insider Sale by Dambkowski Carl (Chief Medical Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Dambkowski Carl, serving as Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 5,500 shares at $84.84 per share, for a total transaction value of $466,619.00. Following this transaction, Dambkowski Carl now holds 208,398 shares of APGE.

This sale represents a 3.00% decrease in Dambkowski Carl's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 3, 2026, 2 days after the trade was made.

Apogee Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Dambkowski Carl

Chief Medical Officer

Carl Dambkowski, MD is the Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), a role he has held since September 2022, where he leads executive clinical strategy.[[1]](https://theorg.com/org/apogee-therapeutics/org-chart/carl-dambkowski)[[2]](https://fintool.com/app/research/companies/ORKA/people/carl-dambkowski)[[3]](https://www.biocom.org/people/carl-dambkowski-md/) A corporate insider who has recently traded in APGE stock, Dambkowski brings extensive experience in biotechnology clinical development and regulatory approvals.[[1]](https://theorg.com/org/apogee-therapeutics/org-chart/carl-dambkowski)[[2]](https://fintool.com/app/research/companies/ORKA/people/carl-dambkowski) Dambkowski earned a B.A. in Psychology (with honors) and M.D. from Stanford University, with physician training concentrated in bioengineering, and an M.A. in Education from Columbia University.[[1]](https://theorg.com/org/apogee-therapeutics/org-chart/carl-dambkowski)[[2]](https://fintool.com/app/research/companies/ORKA/people/carl-dambkowski)[[4]](https://navirepharma.com/team-member/carl-dambkowski-m-d/) His career highlights include senior roles at BridgeBio affiliates—Chief Medical Officer at QED Therapeutics (2021-2022) and Navire Pharma (2020-2022), and Chief Strategy Officer & EVP Operations at Origin Biosciences (2018-2021)—where he contributed to FDA approvals of TRUSELTIQ (infigratinib) and NULIBRY (fosdenopterin).[[2]](https://fintool.com/app/research/companies/ORKA/people/carl-dambkowski)[[3]](https://www.biocom.org/people/carl-dambkowski-md/)[[4]](https://navirepharma.com/team-member/carl-dambkowski-m-d/) Earlier, he was an Associate at McKinsey & Company (2016-2018) advising on R&D strategy, co-founded neonatal device company Novonate, Inc. (2015-present, with patents), and taught as a Second Grade Teacher (2007-2014).[[1]](https://theorg.com/org/apogee-therapeutics/org-chart/carl-dambkowski)[[2]](https://fintool.com/app/research/companies/ORKA/people/carl-dambkowski)[[4]](https://navirepharma.com/team-member/carl-dambkowski-m-d/) He also serves as an Independent Director and Audit Committee member at Oruka Therapeutics (appointed August 2024).[[2]](https://fintool.com/app/research/companies/ORKA/people/carl-dambkowski)

View full insider profile →

Trade Price

$84.84

Quantity

5,500

Total Value

$466,619.00

Shares Owned

208,398

Trade Date

Wednesday, April 1, 2026

3 days ago

SEC Filing Date

Friday, April 3, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Apogee Therapeutics, Inc.

Company Overview

No company information available
View news mentioning APGE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5338351

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime